1. Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR;
2. Service des maladies du sang, Hôpital Claude Huriez, Lille University Hospital, Lille, France;
3. INSERM 1052/CNRS 5286 Cancer Research Center of Lyon, Lyon, France;
4. National Amyloidosis Centre, University College London, London, United Kingdom; and
5. The Institute of Cancer Research, London, United Kingdom